Roniciclib Mass Balance Study

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

June 30, 2016

Conditions
Neoplasms
Interventions
DRUG

roniciclib (BAY 1000394)

Single dose , 2.5 mg roniciclib spiked with 5.0 MBq of \[14C\] roniciclib solution

DRUG

roniciclib (BAY 1000394)

5 mg roniciclib tablet , Multiple dose, twice a day (bid), on a 3-days on/4-days off regimen in cycles of 21 days

Trial Locations (1)

1077

PRA Magyarorszag Kft. Fazis I-es Klin.Farmakol. Vizsgalohely, Budapest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY